Skip to main content
HR 733 112th Congress House

Recalcitrant Cancer Research Act of 2012

Official title: To provide for scientific frameworks with respect to recalcitrant cancers.

Introduced: March 31, 2011 See on congress.gov
Health Advisory bodiesCancerCongressional oversightDepartment of Health and Human Services
More subjectsShow fewer subjects
Digestive and metabolic diseasesDrug therapyHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesMedical educationMedical researchMedical tests and diagnostic methodsNational Institutes of Health (NIH)Research administration and fundingResearch and development
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 20, 2012
Received in the Senate.
Sep 19, 2012
The title of the measure was amended. Agreed to without objection.
Sep 19, 2012
Motion to reconsider laid on the table Agreed to without objection.
Sep 19, 2012
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6144-6145)
Sep 19, 2012
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6144-6145)
Sep 19, 2012
DEBATE - The House proceeded with forty minutes of debate on H.R. 733.
Sep 19, 2012
Considered under suspension of the rules. (consideration: CR H6144-6147)
Sep 19, 2012
Mr. Pitts moved to suspend the rules and pass the bill, as amended.
Sep 11, 2012
Forwarded by Subcommittee to Full Committee (Amended) .
Sep 11, 2012
Subcommittee Consideration and Mark-up Session Held.
Feb 28, 2011
Referred to the Subcommittee on Health.
Feb 16, 2011
Referred to the House Committee on Energy and Commerce.
Feb 16, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 20, 2012

Received in the Senate.

 Plain-English summary Congressional Research Service

Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes: (1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research; (2) identification of research questions that have not been adequately addressed; and (3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions. Requires the Director to develop the framework within 18 months and review and update it every 5 years.

Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer.

Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act.

Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.

 Related & companion bills 5
  • HR 4310 Related bill National Defense Authorization Act for Fiscal Year 2013
  • S 362 Related bill Pancreatic Cancer Research and Education Act
  • S 3254 Related bill National Defense Authorization Act for Fiscal Year 2013
  • S 3560 Related bill Recalcitrant Cancer Research Act of 2012
  • S 3566 Related bill Recalcitrant Cancer Research Act of 2012
 Bill text 3 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 165
All 165 Democratic 56 Republican 23
Roskam, Peter
· Sep 19, 2012
Roby, Martha
· Sep 13, 2012
 D
Carson, André
Indiana · Sep 12, 2012
Franks, Trent
· Sep 12, 2012
MICA, JOHN
· Sep 12, 2012
WALDEN, GREG
· Sep 12, 2012
STEARNS, CLIFF
· Sep 11, 2012
Bishop, Rob
· Sep 10, 2012
Hanabusa, Colleen
· Sep 10, 2012
 D
Luján, Ben Ray
New Mexico · Sep 10, 2012
Renacci, James
· Sep 10, 2012
McCarthy, Kevin
· Aug 7, 2012
Duffy, Sean
· Jul 31, 2012
 R
Simpson, Michael K.
Idaho · Jul 31, 2012
Richmond, Cedric
· Jul 24, 2012
 D
Tonko, Paul
New York · Jul 17, 2012
Yoder, Kevin
· Jul 17, 2012
BONO MACK, MARY
· Jul 9, 2012
 R
Diaz-Balart, Mario
Florida · Jul 9, 2012
 R
Graves, Sam
Missouri · Jul 9, 2012
 R
Latta, Robert E.
Ohio · Jul 9, 2012
LEVIN, SANDER
· Jul 9, 2012
Polis, Jared
· Jul 9, 2012
Chaffetz, Jason
· Jun 28, 2012
WHITFIELD, EDWARD
· Jun 28, 2012
ROS-LEHTINEN, ILEANA
· Jun 27, 2012
Bonner, Jo
· Jun 26, 2012
 R
Kelly, Mike
Pennsylvania · Jun 26, 2012
 D
Sherman, Brad
California · Jun 26, 2012
 R
Blackburn, Marsha
Tennessee · Jun 18, 2012
 D
Bonamici, Suzanne
Oregon · Jun 18, 2012
LATOURETTE, STEVEN
· Jun 18, 2012
 D
Heinrich, Martin
New Mexico · Jun 8, 2012
 R
Harris, Andy
Maryland · May 17, 2012
 D
Larsen, Rick
Washington · May 16, 2012
 R
Womack, Steve
Arkansas · May 16, 2012
 R
Amodei, Mark E.
Nevada · May 7, 2012
Granger, Kay
· Apr 25, 2012
Noem, Kristi
· Apr 24, 2012
 R
Scott, Austin
Georgia · Apr 24, 2012
 D
Wasserman Schultz, Debbie
Florida · Apr 24, 2012
Marchant, Kenny
· Apr 16, 2012
Rodgers, Cathy
· Mar 27, 2012
 D
Larson, John B.
Connecticut · Mar 19, 2012
BIGGERT, JUDY
· Feb 28, 2012
COSTELLO, JERRY
· Feb 16, 2012
BACA, JOE
· Feb 2, 2012
BECERRA, XAVIER
· Feb 2, 2012
 D
Chu, Judy
California · Feb 2, 2012
 D
McCollum, Betty
Minnesota · Feb 2, 2012
Page 1 of 4 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 733: Recalcitrant Cancer Research Act of 2012. 112th Congress. Open America. https://openamerica.io/bill/112-HR-733/
MLA
"H.R. 733: Recalcitrant Cancer Research Act of 2012." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-733/.
Bluebook (legal)
H.R. 733, 112th Cong. (2026), https://openamerica.io/bill/112-HR-733/.
Markdown link
[H.R. 733: Recalcitrant Cancer Research Act of 2012](https://openamerica.io/bill/112-HR-733/)
Report a problem